Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. They include 96 for lung cancer, 79 for breast cancer, 66 for colorectal cancer, and 79 for prostate cancer. Other medicines target brain, kidney, ovarian, pancreatic, skin, and other cancers. Companies are also working on medicines to improve quality of life for those with cancer.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical…  
  • Every additional dollar spent on overall breast cancer treatment has produced health gains valued at $4.80.  
  • The 5-year survival rate for cancer has gone up 40 percent in the last 40 years.  
  • Since Congress passed the National Cancer Act in 1971, the percentage of the U.S. population living with, through, or beyond a cancer diagnosis has more than tripled.  
  • Medical research that resulted in a 1/5 reduction in deaths from cancer would be worth $10 trillion to Americans-double the national debt.